| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/14/1993 | DE4121127A1 Auxiliary esp. binder for use in dry direct tabletting of medicaments - comprises cellulose@ laminated with e.g. highly disperse silica by friction or milling |
| 01/13/1993 | EP0522937A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522936A1 Taxane derivatives containing compositions |
| 01/13/1993 | EP0522433A1 Oral aqueous solutions containing ubidecarenone |
| 01/13/1993 | EP0522286A1 Device and methods for controlled diffusion of a chemical substance |
| 01/13/1993 | EP0522226A1 Eyedrop solution for the treatment of ocular hypertension containing ketauserin |
| 01/13/1993 | EP0522141A1 Method for masking the taste of a medicament |
| 01/13/1993 | EP0522122A1 Pharmaceutical compositions containing amethocaine |
| 01/13/1993 | EP0521988A1 Device and method for iontophoretic drug delivery. |
| 01/13/1993 | EP0521981A1 Process for manufacturing oil-in-water creams. |
| 01/13/1993 | CN1067816A Making method of vital energy and blood tonifying medicine |
| 01/13/1993 | CN1067812A Making method of apoplexy plaster |
| 01/13/1993 | CN1067811A Transdermal nicotine absorption dosage unit and process |
| 01/13/1993 | CN1067810A Sustained releasing capsule and preparation |
| 01/13/1993 | CN1067809A Oral presentation forms for acid-unstable active compounds |
| 01/13/1993 | CA2072726A1 Anti-glaucoma compositions |
| 01/12/1993 | US5179189 Fatty acid terminated polyanhydrides |
| 01/12/1993 | US5179122 Nutritional supplement containing vitamin e |
| 01/12/1993 | US5179086 Containing cholesterol for treatment of psoriasis |
| 01/12/1993 | US5179079 Nasal formulation and intranasal administration therewith |
| 01/12/1993 | US5178947 Magnetizable composite microspheres based on a crosslinked organosilicon polymer |
| 01/12/1993 | US5178882 Viral decoy vaccine |
| 01/12/1993 | US5178881 Anhydrous topical compositions which dry rapidly on contact |
| 01/12/1993 | US5178880 Bactericides for urinary tract infections |
| 01/12/1993 | US5178879 Capsaicin gel |
| 01/12/1993 | US5178878 Tablet with saliva activated agent and protective material; time-release agents; psychotropic drugs |
| 01/12/1993 | US5178877 Cardiovascular disorders |
| 01/12/1993 | US5178876 Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 01/12/1993 | US5178875 Phosphatides with tert-butanol, clarification of water, mixing with solvent then removal |
| 01/12/1993 | US5178874 Intermittent release dosage form |
| 01/12/1993 | US5178868 Dosage form |
| 01/12/1993 | US5178867 Dosage form for delivering drug in short-time period |
| 01/12/1993 | US5178866 Dosage form for delivering drug to the intestine |
| 01/12/1993 | US5178860 Adjuvant complexes and vaccine made therefrom |
| 01/12/1993 | US5178853 Consisting of a bottle of glass or polyethleneterephthalate with a dropper of polypropylene or polyethylene coated bromobutyl rubber |
| 01/12/1993 | US5178850 Crystalline sugar alcohol containing uniformly dispersed liquid pharmaceutical compound |
| 01/12/1993 | US5178635 Method for determining amount of medication in an implantable device |
| 01/12/1993 | US5178143 Electrically conductive gel composition |
| 01/12/1993 | CA1312616C Hydrophobic cis-platinum complexes efficiently incorporated into liposomes |
| 01/12/1993 | CA1312549C Instant oral-release capsule containing nifedipine |
| 01/12/1993 | CA1312548C Spherical granules having core and their production |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |
| 01/10/1993 | CA2072950A1 Pharmaceutical and its use for the treatment of states of agitation and nerve dysfunction |
| 01/07/1993 | WO1993000388A1 Method of preparing nanoparticles |
| 01/07/1993 | WO1993000383A1 Pulsed release of high molecular weight therapeutic agents from bioerodible polymer compositions |
| 01/07/1993 | WO1993000160A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | WO1993000128A1 Renewable neural implant device and method |
| 01/07/1993 | WO1993000115A1 Device for controlled release of vaporous medications and insect-repellents |
| 01/07/1993 | WO1993000114A1 Topical composition enhancing healing of herpes lesions |
| 01/07/1993 | WO1993000101A1 Nanoparticles based on a polyoxyethylene and polylactic acid block copolymer |
| 01/07/1993 | WO1993000100A2 Wound cleanser |
| 01/07/1993 | WO1993000097A1 Pharmaceutical preparations containing torasemid |
| 01/07/1993 | WO1993000093A1 Extended-release form of diltiazem |
| 01/07/1993 | WO1993000085A1 Stabilized retinoid-containing skin care compositions |
| 01/07/1993 | WO1993000080A1 Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions |
| 01/07/1993 | WO1993000078A1 Molecular encapsulation and delivery of alkanes to living mammalian cells for risk assessment and pharmaceutical application |
| 01/07/1993 | WO1993000077A1 Orally administrable therapeutic proteins and method of making |
| 01/07/1993 | WO1993000076A1 Carrier systems for drugs |
| 01/07/1993 | WO1993000075A1 Methods and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 01/07/1993 | WO1993000074A1 Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron |
| 01/07/1993 | WO1993000073A1 Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| 01/07/1993 | WO1993000072A1 Process for solubilizing difficultly soluble pharmaceutical actives |
| 01/07/1993 | WO1993000071A1 Dosage form for a delayed drug delivery |
| 01/07/1993 | WO1993000070A1 Controlled release systems and low dose androgens |
| 01/07/1993 | WO1993000069A1 Vesicles in non-polar media |
| 01/07/1993 | WO1993000067A1 Cosmetic compositions containing oligosaccharides |
| 01/07/1993 | WO1993000058A1 Solubility parameter based drug delivery system and method for altering drug saturation concentration |
| 01/07/1993 | WO1993000052A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000051A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | WO1993000050A1 Pharmaceutical formulations of osteogenic proteins |
| 01/07/1993 | WO1992019209A3 Taste-masked medicaments and their preparation |
| 01/07/1993 | EP0521799A1 Ophthalmic compositions |
| 01/07/1993 | EP0521680A1 3-Oxygermylpropionic acid compressed compositon and its use against cytopathogenic substances |
| 01/07/1993 | EP0521562A1 Vesicles in non-polar media |
| 01/07/1993 | EP0521455A2 Aerosol composition containing a film-forming hydroxycarboxylic acid polymer |
| 01/07/1993 | EP0521388A1 Process for the preparation of a pharmaceutical preparation containing at least two different actives and use thereof |
| 01/07/1993 | EP0521310A2 Solid dispersion tablets containing 1,4-dihydropyridine derivatives and process for the preparation thereof |
| 01/07/1993 | EP0521225A1 Pharmaceutical preparation for treatment of periodontitis, containing clavulanic acid |
| 01/07/1993 | EP0521070A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief. |
| 01/07/1993 | EP0520983A1 Calcitonin suppository formulations |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | EP0247142B1 Film-forming, pharmaceutical vehicles for application of medicaments to nails, pharmaceutical compositions based on those vehicles, and methods of using same |
| 01/07/1993 | DE4121820A1 Microcapsule dispersion contg. ionogenic protective colloid and salt - has high stability and low viscosity, suitable for encapsulation of drugs, agrochemicals. dyes, etc. |
| 01/07/1993 | CA2112488A1 Method and compositions for treating emesis, nausea and other disorders using optically pure s(-) ondansetron |
| 01/07/1993 | CA2112393A1 Controlled release systems and low dose androgens |
| 01/07/1993 | CA2112385A1 Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
| 01/07/1993 | CA2112376A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112375A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 01/07/1993 | CA2112356A1 Multiple emulsions and methods of preparation |
| 01/07/1993 | CA2112123A1 Wound cleanser |
| 01/07/1993 | CA2111978A1 Renewable neural implant device and method |
| 01/07/1993 | CA2111837A1 Topical composition enhancing healing of herpes lesions |
| 01/06/1993 | CN1067583A Method for preparing stomatitis spray |
| 01/06/1993 | CN1067580A Megestrol acetate formulation |
| 01/06/1993 | CN1067579A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067578A Non-chlorofluorocarbon aerosol formulations |
| 01/06/1993 | CN1067577A Pharmaceutical formulations |
| 01/06/1993 | CA2073141A1 Ophthalmic compositions |
| 01/05/1993 | US5177110 Injectable parasiticidal composition |
| 01/05/1993 | US5177076 Aqueous folinate solution stable at refrigerator temperature, as well as process for its preparation |